Impact of psychological distress on outcomes in cancer patients

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 2, Issue 5, 2002, Pages 495-506

  Fang, Carolyn Y ^a   Schnoll, Robert A ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Behavioral adherence; Cancer; Intervention; Psychological distress; Quality of life

Indexed keywords

BEHAVIOR THERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURVIVAL; CANCER THERAPY; CAUSE OF DEATH; CLINICAL RESEARCH; COGNITIVE THERAPY; CONTROLLED STUDY; COPING BEHAVIOR; DISEASE SEVERITY; DISTRESS SYNDROME; HEALTH BEHAVIOR; HUMAN; METHODOLOGY; PATIENT COMPLIANCE; PROGNOSIS; PSYCHOSOCIAL CARE; QUALITY OF LIFE; REVIEW; UNITED STATES;

EID: 0036798147     PISSN: 14737167     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737167.2.5.495     Document Type: Review

References (106)

1. Holland JC. Pycho-Oncology, Oxford University Press, New York, NY, USA (1998).
2. Harrison J, Maguire P. Predictors of psychiatric morbidity in cancer patients. Br. J. Psychiatry 165, 593-598 (1994).
3. Hopwood P, Howell A, Maguire P. Psychiatric morbidity in patients with advanced cancer of the breast Prevalence measured by two self-rating questionnaires. Br. J. Cancer 64, 349-352 (1991).
4. Holland JC, Hughes AH, Tross S et al. Comparative psychological disturbance in-patients with pancreatic and gastric cancer. Am. J. Psychiatry 143, 982-986 (1986).
5. Ell K, Nishimoto R, Morvay T, Mantell J, Hamovitch M. A longitudinal analysis of psychological adaptation among survivors of cancer. Cancer 63, 406-413 (1989).
6. Gritz ER, Wellish DK, Landsverk JA. Psychosocial sequalae in long-term survivors of testicular cancer. J. Psychosocial Oncology 6, 41-63 (1989).
7. Cella DF, Orrofiamma B, Holland JC et al. The relationship of psychological status in patients with lung cancer. Cancer 60, 1661-1667 (1987).
8. Devlen J, Maguire P, Phillips P, Crowther D. Psychological problems associated with diagnosis and treatment of lymphomas: A prospective study. Br. Med. J. 295, 955-957 (1987).
9. Lesko LM. Hematological malignancies. In: Handbook of Psychooncology. Psychological care of the patient with cancer. Holland JC, Rowland JH (Eds), Oxford University Press, New York, NY, USA (1989).
10. Baile WF, Gibertini M, Scott L, Endicott J. Depression and minor stage in cancer of the head and neck. Psycho-Oncology 1, 15-24 (1992).
11. Brandberg Y, Bolund C, Sigurdardottir V, Sjoden PO, Sullivan M. Anxiety and depression at different stages of malignant melanoma. Pycho-Oncology 1, 71-78 (1992).
12. Heilgenstein E, Holland JC. Malignant bone tumors. In: Handbook of Psychooncology: Psychological care of the patient with cancer. Holland JC, Rowland JH (Eds), Oxford University Press, New York, NY, USA (1989).
13. Lynch ME. The assessment and prevalence of affective disorders in advanced cancer. J Palliative Care 11, 10-18 (1995).
14. Worden J. The experience of recurrent cancer. CA-A Cancer J. Clinicians 39, 305-310 (1989).
15. Andersen BL, Kiecolt-Glaser J, Glaser R. A biobehavioral model of cancer stress and disease course. Am. Psychol. 49, 389-404 (1994).
16. Litwin MS, Hays RD, Fink A, Ganz PA Quality of life outcomes in men treated for localized prostate cancer. JAMA 273(2), 129-135 (1995).
17. Fayers PM, Hopwood P, Harvey A, Girling DJ, Machin D, Stephens R. Quality of life assessment in clinical trials-guidelines and a checklist for protocol writers: the UK Medical Research Council Experience. Eur. J. Cancer 33(1), 20-28 (1997).
18. Ganz PA, Coscarelli A, Fred C, Kahn B, Polinsky ML, Petersen L. Breast cancer survivors: Psychosocial concerns and quality of life. Breast Cancer Res. Treat. 38, 183-199 (1996).
19. Schag CAC, Heinrich R. Cancer Rehabilitation and Evaluation System manual. Cares Consultants, Los Angeles, CA, USA (1989).
20. Lutgendorf SK, Anderson B, Ullrich P et al. Quality of life and mood in women with gynecologic cancer: A one year prospective study. Cancer 94, 131-140 (2002).
21. Anderson BL, Anderson B, deProsse C. Controlled longitudinal study of women with cancer I. Sexual functioning outcomes. J. Consult. Clin. Psychology 57, 683-691 (1989).
22. Bodurka-Bevers D, Basen-Engquist K, Camark CL et al. Depression, anxiety and quality of life in patients with epithelial ovarian cancer. Gynecol. Oncol 78, 302-308 (2000).
23. Klee M, Thranov I, Machin D. Life after radiotherapy: The psychological and social effects experienced by women treated for advanced stages of cervical cancer. Gynecol. Oncol. 76, 5-13 (2000).
24. Corney RH, Everett H, Howells A, Crowther ME. Psychosocial adjustment following major gynaecological surgery for carcinoma of the cervix and vulva. J. Psychosom. Res. 36, 561-568 (1992).
25. Stone P, Richards M, A'Hern R, Hardy J. Fatigue in patients with cancers of the breast or prostate undergoing radical radiotherapy J. Pain Symptom Manage. 22(6), 1007-1015 (2000).
26. Smets E, Visser M, Willems-Groot A et al. Fatigue and radiotherapy: (A) experience in patients undergoing treatment. Br. J. Cancer 78, 899-906 (1998).
27. Biondi M. Effects of stress on immune functions: An overview. In: Pychoneuroimmunology (Volume 2) 3rd edition. Ader R, Felten DL, Cohen N (Eds), Academic Press, New York, NY, USA, 189-226 (2001).
28. Ketchel SJ, Rodriguez V: Acute infections in cancer patients. Semin. Oncology 5, 167-179 (1987).
29. Whiteside TL, Herberman RB. The role of natural killer cells in immune surveillance of cancer. Curr. Opin. Immunol. 7, 704-710 (1995).
30. Levy S, Herberman R, Lippman M, d'Angelo T. Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. J. Clin. Oncology 5, 348-353 (1987).
31. Andersen BL, Farrar WB, Golden-Kreutz D et al. Stress and immune responses after surgical treatment for regional breast cancer. J. Natl Cancer Inst. 90, 30-36 (1998).
32. Orsi A. McCorkle R, Tax A, Barsevick A. The relationship between depressive symptoms and immune status phenotypes in patients undergoing surgery for colorectal cancer. Psycho-Oncology 5, 311-319 (1996).
33. Tjemsland L, Soreide JA, Malt UF. Posttraumatic distress symptoms in operable breast cancer III: Status one year after surgery. Breast Cancer Res. Treat. 47, 141-151 (1998).
34. Bovbjerg D, Redd WH, Maier SF et al. Anticipatory immune suppression and nausea in women receiving cyclic chemotherapy for ovarian cancer. J. Consult. Clin. Psychology 58, 153-157 (1990).
35. Fredrikson M, Furst C, Lekander M, Rotstein S, Blomgren H. Trait anxiety and anticipatory immune reactions in women receiving adjuvant chemotherapy for breast cancer. Brain Behav. Immun. 7, 79-90 (1993).
36. DeKeyser FG, Wainstock JM, Rose L, Converse PJ, Dooley W. Distress, symptom distress and immune function in women with suspected breast cancer. Oncology Nursing Forum 25(8), 1415-1422 (1998).
37. Tishiro M, Itoh M, Kubota K et al. Relationship between trait anxiety, brain activity and natural killer cell activity in cancer patients: A preliminary PET study. Psycho-Oncology 10, 541-546 (2001).
38. van der Pompe G, Antoni MH, Visser A, Heijnen CJ. Effect of mild acute stress on immune cell distribution and natural killer cell activity in breast cancer patients. Biological Psychology 48, 21-35 (1998).
39. Aragona M, Muscatello M, Losi E et al. Lymphocyte number and stress parameter modifications in untreated breast cancer patient with depressive mood previous life stress. J. Exp. Therapeut. Oncology 1, 354-360 (1996).
40. Finn OJ. Assessing the important effector mechanisms in the immune response against cancer. In: Psychosocial Interventions for Cancer. Baum A, Andersen BL, (Eds), American Psychological Association Press, Washington, DC, USA, 175-192 (2001).
41. Shimizu Y, Veidmann E, Iwatsuki S, Herberman RB, Whiteside TL. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma. Cancer Res. 51, 6153-6162 (1991).
42. Lutgendorf S, Anderson B, Sorosky JI, Buller RE, Lubaroff DM. Interleukin-6 and use of social support in gynecologic cancer patients. Int, J. Behav. Med. 7(2), 127-142 (2000).
43. Musselman D, Miller A. Porter M et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: Preliminary findings. Am. J. Psychiatry 158(8), 1252-1257 (2001).
44. Borden EC, Sondel PM. Lymphokines and cytokines as cancer treatment. Cancer 65, 800-884 (1990).
45. Andrykowski MA, Brady MJ, Henslee-Downey PJ. Psychosocial factors predictive of survival after allogenic bone marrow transplantation for leukemia. Psychosomatic Med. 56, 432-439 (1994).
46. Kukull WA, McCorkle R, Criever M. Symptom distress, psychosocial variables and survival from lung cancer. J. Psychosoc. Oncol. 4, 91-104 (1986).
47. Molassiotis A. Van Den Akker OBA Milligan DW, Goldman JM. Symptom distress, coping style and biological variables as predictors of survival after bone marrow transplantation. J. Psychosomatic Res. 42, 275-285 (1997).
48. Derogatis LR, Abeloff MD, Melisaratos N. Psychological coping mechanism and survival time in metastatic breast cancer. J. Am. Med. Assoc. 242, 1504-1508 (1979).
49. Dean C. Surtees PG. Do psychological factors predict survival in breast cancer? J. Psychosomatic Res. 33, 561-569 (1989).
50. Fawzy FI, Fawzy NW, Hyun CS et al. Malignant melanoma: effects of an early structured psychiatric intervention, coping and affective state on recurrence and survival 6 years later. Arch. Gen. Psychiatry 50, 681-689 (1993).
51. Ratcliffe MA, Dawson AA, Walker LG. Eysenck Personality Inventory L-scores in patients with Hodgkin's disease and non-Hodgkins lymphoma. Psycho-Oncology 4, 39-45 (1995).
52. Levy SM, Herberman RB, Lippman M, D'Angelo T Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer. Behav. Med 67-75 (1991).
53. Kogon MM, Biswas A, Pearl D, Carlson RW, Spiegel D. Effects of medical and psychotherapeutic treatment on the survival of women with metastatic breast carcinoma. Cancer 80, 225-230 (1997).
54. Richardson JL, Shelton DR, Krailo M, Levine AM. The effect of compliance with treatment on survival among patients with hematologic malignancies. J. Clin. Oncol. 8, 356-364 (1990).
55. Kuchler T, Henne-Bruns D, Rappat S et al. Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery: survival results of a trial. Hepatogastroenterology 46, 322-335 (1999).
56. Spiegel D. Mind matters - group therapy and survival in breast cancer. N. Engl. J. Med. 345, 1767-1768 (2001).
57. Spiegel D. Psychological distress and disease course for women with breast cancer One answer, many questions. J. Natl Cancer Inst. 88, 629-631 (1996).
58. Fawzy FI, Cousins N, Fawzy NW, Kemeny MF, Elashoff R, Morton D. A structured psychiatric intervention for cancer patients: II. Changes over time in immunological measures. Arch. Gen. Psychiatry 47, 729-735 (1990).
59. Garssen B, Goodkin K. On the role of immunological factors as mediators between psychosocial factors and cancer progression. Psychiatry Res. 85, 51-61 (1999).
60. Goodkin K. Antoni MH, Blaney PH. Stress and hopelessness in the promotion of cervical intraepithelial neoplasia to invasive squamous cell carcinoma of the cervix. J. Psychosomatic Res. 30, 67-76 (1986).
61. Eysenck HJ. Synergistic interaction between psychosocial and physical factors in the causation of lung cancer. In: The Psychoimmunology of Cancer. Mind and Body in the Fight for Survival. Lewis CE, O'Sullivan C, Barraclough J (Eds), Oxford Medical Publ., Oxford, UK, 163-178 (1994).
62. Dunbar-Jacob J, Schlenk E. Patient adherence to treatment regimen. In: Handbook of Health Psychology. Baum A, Revenson TA. Singer JE (Eds), Lawrence Erlbaum, Mahwah, NJ, USA, 571-580 (2001).
63. Lee CR, Nicholson PW, Souhami RL, Slevin ML, Hall MR, Deshmukh AA. Patient compliance with prolonged low-dose oral etoposide for small cell lung cancer. Br. J. Cancer 67, 630-634 (1993).
64. Li BD, Brown WA, Ampil FL, Burton GV, Yu H, McDonald JC. Patient compliance is critical for equivalent clinical outcomes for breast cancer treated by breast-conservation therapy. Ann. Surg. 231, 883-889 (2000).
65. Partridge AH, Avorn J, Wang PS, Winer EP. Adherence to therapy with oral antineoplastic agents. J. Natl Cancer Inst. 94, 652-661 (2002).
66. Lebovits AH, Strain JJ, Schleifer SJ, Tanaka JS, Bhardwaj S, Messe MR. Patient noncompliance with self-administered chemotherapy. Cancer 65, 17-22 (1990).
67. McDaniel SJ, Musselman DL, Nemeroff CB. Cancer and depression: theory and treatment. Psychiatr. Ann. 27, 360-364 (1997).
68. Pirl WF, Roth AJ. Diagnosis and treatment of depression in cancer patients. Oncology (Huntingt.) 13, 1293-1301 (1999).
69. McDonough EM, Boyd JH, Varvares MA, Maves MD. Relationship between psychological status and compliance in a sample of patients treated for cancer of the head and neck. Head Neck 18, 269-276 (1996).
70. Simmons K, Lindsay S. Psychological influences on acceptance of post-surgical treatment in cancer patients. J. Psychosom. Res. 51, 355-360 (2001).
71. Gilbar O, De-Nour. Adjustment to illness and dropout of chemotherapy. J. Psychosom. Res. 33, 1-5 (1989).
72. Botelho RJ, Dudrak R. Home assessment of adherence to long-term medication in the elderly. J. Fam. Pract. 35, 61-65 (1992).
73. DiMatteo MR. Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch. Intern. Med. 160, 2101-2107 (2000).
74. Holm LE, Nordevang E, Ikkala E, Hallstrom L, Callmer E. Dietary intervention as adjuvant therapy in breast cancer patients - a feasibility study. Breast Cancer Res. Treat. 16, 103-109 (1990).
75. Demark-Wahnefried W, Peterson B, McBride C, Lipkus I, Clipp E. Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas. Cancer 88, 674-684 (2000).
76. Schnoll RA, Lerman, C, Smoking behavior and smoking cessation among head and neck cancer patients. In. Head and Neck Cancers. Ensley JF, Gutkind JS, Jacobs JR, Lippman SM (Eds). Academic Press, San Diego, CA, USA (In Press).
77. Gritz ER, Schacherer C, Koehly L, Nielsen IR, Abemayor E. Smoking withdrawal and relapse in head and neck cancer patients. Head Neck 21, 420-427 (1999).
78. Fujisawa T, Iizasa T, Saitoh Y et al. Smoking befbre surgery predicts poor long-term survival in patients with Stage I non-small-cell lung carcinomas. J. Clin. Oncol. 17, 2086-2091 (1999).
79. Schnoll RA, Malstrom M, James C et al. Correlates of tobacco use among smokers and recent quitters diagnosed with cancer. Pat. Educ. Couns. 46, 141-152 (2002).
80. Quattrocki E, Baird A, Yurgelun-Todd D. Biological aspects of the link between smoking and depression. Harv. Rev. Psychiatry 8, 99-110 (2000).
81. Redd WH, Montgomery GH, DuHamel KN. Behavioral intervention for cancer treatment side effects. J. Natl Cancer Inst. 93, 810-823 (2001).
82. Owen JE, Klapow JC, Hicken B, Tucker DC. Psychosocial interventions for cancer. Review and analysis using a three-tiered outcomes model. Psychooncology 10, 218-230 (2001).
83. Meyer TJ, Mark MM. Effects of psychosocial interventions with adult cancer patients: a meta-analysis of randomized experiments. Health Psychol. 14, 101-108 (1995).
84. Compas BE, Haaga DA, Keefe FJ, Leitenberg H, Williams DA. Sampling of empirically supported psychological treatments from health psychology: smoking, chronic pain, cancer and bulimia nervosa. J. Consult. Clin. Psychol. 66, 89-112 (1998).
85. Walker BL, Nail LM, Croyle RT. Does emotional expression make a difference in reactions to breast cancer? Oncol, Nurs. Forum 26, 1025-1032 (1999).
86. Gustafson DH, Bosworth K, Hawkins RP, Boberg EW, Bricker E. CHESS: a computer-based system for providing information, referrals, decision support and social support to people facing medical and other health-related crises. Proc. Ann. Symp. Com. Applic. Med. Care 161-165 (1992).
87. McTavish FM, Gustafson DH, Owens BH et al. CHESS (Comprehensive Health Enhancement Support System): an interactive computer system for women with breast cancer piloted with an underserved population. J. Ambulatory Care Manage. 18, 35-41 (1995).
88. Gustafson DH, Hawkins R. Pingree S et al. Effect of computer support on younger women with breast cancer. J. Gen. Intern. Med. 16, 435-445 (2001).
89. Luebbert K, Dahme B, Hasenbring M. The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment a meta-analytical review. Psychooncology 10, 490-502 (2001).
90. Antoni MH, Lehman JM, Kilbourn KM et al. Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychol. 20, 20-32 (2001).
91. Baider L, Peretz T, Hadani PE, Koch U. Psychological intervention in cancer patients: a randomized study. Gen. Hosp. Psychiatry 23, 272-277 (2001).
92. Fawzy FI, Fawzy NW, Arndt LA, Pasnau RO. Critical review of psychosocial interventions in cancer care. Arch. Gen. Psychiatry 52, 100-113 (1995).
93. Spiegel D, Bloom JR, Kraemer HC, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 14, 888-891 (1989).
94. Esplen MJ, Toner B, Hunter J et al. A supportive-expressive group intervention for women with a family history of breast cancer: results of a Phase II study. Psychooncology 9, 243-252 (2000).
95. Classen C, Butler LD, Koopman C et al. Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial. Arch. Gen. Psychiatry 58, 494-501 (2001).
96. Cunningham AJ, Tocco EK. A randomized trial of group psychoeducational therapy for cancer patients. Patient Educ. Counsel 14, 101-114 (1989).
97. Telch CF, Telch MJ. Group coping skills instruction and supportive group therapy for cancer patients: a comparison of strategies. J. Consult. Clin. Psychol 54, 802-808 (1986).
98. Evans RL, Connis RT. Comparison of brief group therapies for depressed cancer patients receiving radiation treatment. Public Health Reports 110, 306-311 (1995).
99. Coyne JC, Duan N, Barg F, Palmer S, Kagee A. The crisis of psychosocial intervention in cancer and quality engineering as a resolution. Ann. Behav. Med. 23, S122 (2001).
100. Kagee A, Palmer S, Kruus L, Thompson R, Coyne J. Moderate distress among head and neck cancer patients. Ann. Behav. Med. 24, S167 (2002).
101. Kurtz ME, Wyatt G, Kurtz JC. Psychological and sexual well-being, philosophical/spiritual views and health habits of long-term cancer survivors. Healthcare for Women Int. 16, 253-262 (1995).
102. Wydra EW. The effectiveness of a self-care management interactive multimedia module. Oncol. Nurs. Forum 28(9), 1399-1407 (2001).
103. Miller SM, Fang CY, Diefenbach MA, Bales CB. Tailoring psychosocial intervention's to the individual's health information processing style: The influence of monitoring versus blunting in cancer risk and disease. In: Psychosocial interventions and cancer Baum A, Andersen BL (Eds), American Psychological Association Press, Washington, DC, USA, 343-362 (2001).
104. Brug J, Glanz K, Van Assema P, Kok G, Van Breukelen GJP. The impact of computer-tailored feedback and iterative feedback on fat, fruit and vegetable intake. Health Education Behavior 25(4), 517-531 (1998).
105. Gattuso SM, Litt MD, Fitzgerald TE. Coping with gastrointestinal endoscopy: Self-efficacy enhancement and coping style. J. Consult. Clin. Psychology 60, 133-139 (1992).
106. Miller SM, Buzaglo JS, Simms S et al. Monitoring styles in women at risk for cervical cancer: Implications for the framing of health-relevant messages. Ann. Behav. Med. 21(1), 27-34 (1999).